Kate Therapeutics Funding & Investors
San Diego, CA
Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
katetherapeutics.comTotal Amount Raised: $72,775,024
Kate Therapeutics Funding Rounds
Series B
$21,775,022
Series A
$51,000,000
Series A Investors
Versant VenturesWestlake Village BioPartnersOUP (Osage University Partners)UF Innovate Ventures
Funding info provided by Diffbot.